Fluorophore labeling of a cell-penetrating peptide induces differential effects on its cellular distribution and affects cell viability
- 1 December 2017
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1859 (12) , 2483-2494
Abstract
No abstract availableKeywords
Funding Information
- European Union's Seventh Framework Programme (FP7/2007-2013)
- Danish Council for Independent Research, Technology and Production Sciences (4005-00455)
This publication has 69 references indexed in Scilit:
- Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass spectrometry quantificationScientific Reports, 2016
- Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated formInternational Journal of Pharmaceutics, 2016
- In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratinJournal of Controlled Release, 2014
- Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategiesNature Reviews Drug Discovery, 2014
- Cell entry of cell penetrating peptides: tales of tails wagging dogsJournal of Controlled Release, 2012
- Usefulness of cell-penetrating peptides to improve intestinal insulin absorptionJournal of Controlled Release, 2008
- Deletion analogues of transportanBiochimica et Biophysica Acta (BBA) - Biomembranes, 2000
- A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell NucleusJournal of Biological Chemistry, 1997
- Tat-mediated delivery of heterologous proteins into cells.Proceedings of the National Academy of Sciences, 1994
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988